Impact of novel agents on patient-relevant outcomes in patients with previously untreated chronic lymphocytic leukemia who are not eligible for fludarabine-based therapy.
about
Impact of novel agents on patient-relevant outcomes in patients with previously untreated chronic lymphocytic leukemia who are not eligible for fludarabine-based therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Impact of novel agents on pati ...... for fludarabine-based therapy.
@en
type
label
Impact of novel agents on pati ...... for fludarabine-based therapy.
@en
prefLabel
Impact of novel agents on pati ...... for fludarabine-based therapy.
@en
P2093
P2860
P1476
Impact of novel agents on pati ...... for fludarabine-based therapy.
@en
P2093
Moushmi Singh
Sarah Cote
Simona Baculea
Stuart Mealing
P2860
P356
10.1080/13696998.2017.1357563
P407
P577
2017-07-19T00:00:00Z